Free freight over $200 CAD 1 business day dispatch 99%+ purity specification Third-party HPLC and purity testing Held and shipped in Canada Save up to 35% at 10+ vials Free freight over $200 CAD 1 business day dispatch 99%+ purity specification Third-party HPLC and purity testing Held and shipped in Canada Save up to 35% at 10+ vials
Tier pricing Browse catalogue →
Bulk Peptides logo
[email protected]
Peptide Adsorption to Labware: Glass, Plastic and Low-Bind Tubes

Peptide Adsorption to Labware: Glass, Plastic and Low-Bind Tubes

A lab receives a multi-vial research order, weighs out a portion, prepares a stock and then a dilute working standard. The stock reads as expected. The working standard reads low, and a second preparation reads low again. Before anyone questions the lot, it is worth considering peptide adsorption to labware: the tendency of peptides to cling to the walls of tubes, tips, vials and filters. At low concentrations a surprising share of the material can end up on plastic or glass instead of in solution. This article explains why it happens, which containers suit which sequences, and how a QC team can measure the loss rather than guess at it.

What is happening at the container wall

Adsorption means molecules collecting on a surface instead of staying dispersed in the liquid. Peptides are prone to it because a single chain can grip a surface in several ways at once:

  • Electrostatic attraction between charged side chains (lysine, arginine, aspartate, glutamate, the termini) and charged sites on the surface.
  • Hydrophobic contact between non-polar residues such as leucine, isoleucine, phenylalanine or tryptophan and a non-polar surface.
  • Hydrogen bonding between backbone amides, polar side chains and surface groups.

Longer, more flexible sequences can make many contacts simultaneously, so once they attach they tend to stay attached. That is why adsorption is a bigger concern for peptides than for many small molecules.

Glass or polypropylene: it depends on the sequence

There is no container material that suits every peptide. The right choice follows from the chemistry of the sequence you are handling.

SurfaceMain way it bindsSequences most at risk
Untreated borosilicate glassNegatively charged silanol groups attract positive charge near neutral pHBasic peptides rich in lysine or arginine
Standard polypropyleneHydrophobic surface attracts non-polar residuesHydrophobic or amphipathic peptides, lipidated sequences
Low-bind (surface-treated) polypropyleneReduced ionic and hydrophobic interactionLower risk across the board, but not zero
Deactivated or silanised glassSilanol groups capped, less ionic bindingUseful for basic peptides; check compatibility with your method

A useful habit for a lab handling a varied catalogue is to note, for each compound it stocks, whether the sequence is predominantly basic, acidic or hydrophobic, and to record the container type that worked best. That note saves the next analyst from rediscovering the problem.

Why dilute solutions lose the most

Any given container offers a limited area, and that area can hold only so much peptide before its binding sites are occupied. The amount that sticks is therefore roughly constant for a particular tube and sequence, regardless of how much you put in. What changes with concentration is the fraction that disappears.

Consider a purely illustrative case. Suppose the inner wall of a tube can hold about half a microgram of a given peptide. In a millilitre of stock at 1 mg/mL, losing half a microgram is invisible. In a millilitre of working standard at 1 µg/mL, the same half-microgram is half the sample.

Serial dilution stacks the effect. Each new tube and each new tip takes its own share, and because the solution gets weaker with every step, each share is a larger fraction of what remains. A four-step dilution can finish well below its nominal value even though no single step looked unusual. This is the reason the problem appears in the dilute end of a workflow and is so often blamed on something else.

Surfaces in a preparation that nobody counts

When people think about adsorption they picture the storage vial. In practice the vial is only one of several surfaces a sample meets:

  • Pipette tips, which offer a large wall area relative to the volume they hold and a fresh surface with every change. Their contribution adds to the volumetric bias discussed in pipetting accuracy for peptide solutions.
  • Autosampler vials and inserts, where a dilute sample may sit for hours in a queue before injection.
  • Syringe filters and membranes, designed with high surface area.
  • Intermediate mixing tubes used only for a moment during a transfer.
  • Reservoirs and troughs used with multichannel pipettes, which expose a thin layer of liquid over a wide area.

When loss changes the purity picture

If every component of a sample adsorbed to the same degree, the only consequence would be a lower concentration. In reality the target peptide and its related impurities, such as deletion sequences or oxidised forms, rarely share the same surface affinity.

When the main peptide binds more strongly than an impurity, the solution left behind is relatively enriched in that impurity, and an HPLC purity measured on it comes out lower than the true value. When the impurity binds more strongly, the measured purity flatters the material. Aggregated species can behave differently again. In both directions the chromatogram looks perfectly ordinary, with normal peak shapes and no unexpected peaks. Only a deliberate recovery comparison reveals it.

Reducing peptide adsorption to labware

No single step removes the problem entirely, but several together bring it under control:

  1. Use low-bind tubes and tips for dilute solutions. They reduce binding substantially without eliminating it.
  2. Add a modest amount of organic solvent to the diluent where the downstream method tolerates it. A small percentage of acetonitrile weakens hydrophobic binding noticeably.
  3. Adjust pH away from the isoelectric point to change the peptide’s net charge, keeping in mind the solubility effects covered in isoelectric point and solubility.
  4. Condition the surface first. Rinse the container or tip with a portion of the same solution and discard it, so binding sites are occupied before the portion you keep arrives.
  5. Cut the number of transfers. Prepare the final dilution directly in the vial it will be analysed from wherever possible.
  6. Keep dilute standards short-lived. Prepare them close to the time of analysis instead of holding them in the autosampler queue for long periods.
  7. Reserve carrier proteins and surfactants for bioassay work. They block binding sites effectively but add components that interfere with analytical methods.

A recovery check to add to your receiving SOP

For a lab that brings in the same compounds repeatedly across many lots, a one-time recovery study per compound and container type is cheap insurance. A simple version:

  1. Prepare the working standard in your usual container and measure it immediately.
  2. Transfer it to a fresh container of the same type, hold it for the time your normal workflow would, and measure again.
  3. Repeat with a low-bind container, or with a small amount of organic solvent in the diluent, for comparison.

A drop between the first and second readings, with nothing else changed, is adsorptive loss. Where the sequence contains tryptophan or tyrosine, an absorbance reading as described in peptide concentration by A280 offers a quick independent comparison against the nominal value. File the results with the compound’s handling notes so later lots are prepared the same way.

Keep in mind that the laboratory producing a certificate of analysis faced the same effect when preparing its own solutions and will have managed it within its method. When a dilute solution in your lab reads low, the cheapest explanation to rule out first is that part of the peptide is still on the wall of a tube.

Bulk Peptides supplies its products for in-vitro research and analytical laboratory work only, and none of them is intended for use in humans or animals.

Leave a Comment

Your email address will not be published. Required fields are marked *

*
*

Legal Disclaimer

The products offered by Bulk Peptides are intended solely for research purposes. These products are not for human consumption, are not intended for medical use, and have not been approved by the FDA or Health Canada for any therapeutic or diagnostic purpose. Bulk Peptides makes no claims regarding the safety, efficacy, or intended use of these products outside of a controlled research environment. By purchasing our products, you agree to use them strictly for scientific research and in compliance with all local laws and regulations.

GLP-1 15mg research peptide vial - Bulk Peptides Canada
Wholesale enquiries

Tell us what your lab runs through in a year.

If your lab reorders the same few compounds every quarter, send us the list and the volume and we will come back with a custom quote and a delivery schedule that fits your study calendar, usually inside one business day.

Request bulk pricing → Browse 42 products No account needed to see tier pricing. Every price on this site is already the price you pay.
0
    0
    Your Cart
    Your cart is empty